D-0288-2022 Class II Terminated

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0288-2022 was initiated by Denver Solutions, LLC DBA Leiters Health on Nov 29, 2021 and is designated Class II. Reason for recall: Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL The recall status is terminated (terminated Jul 12, 2022). Affected quantity: 1440 vials.

Recall details

Product Type
Drugs
Report Date
Dec 29, 2021
Initiation Date
Nov 29, 2021
Termination Date
Jul 12, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1440 vials

Product description

Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42

Reason for recall

Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL

Distribution pattern

Nationwide within the United States

Code information

Lot #: 2130958; Expiration Date 03/31/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0288-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0288-2022. Report a data issue: hello@regdatalab.com.